“…In this particular study, scRNA‐seq was performed in 12 treatment‐naïve patients with colorectal cancer at stages I–IV, whole‐exome sequencing in seven patients, and scATAC‐seq in six patients. 18 Clinical studies on immune single‐cell profiles can also provide valuable information for understanding the effects of immune cells within systemic and local environments on disease severity, stage, and response to therapy. For example, 18 patients with breast cancer were enrolled and divided into four groups based on luminal A and B, HER‐2, and TNBC subtypes, into two groups on biopsies and surgical sections, on different sites of the tumour, or pre‐ and postoperation, as well as into three groups on pre, mid‐, and posttreatments with drugs.…”